<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/E4599F86-E5D9-40AD-A427-4782E12EA8BF"><gtr:id>E4599F86-E5D9-40AD-A427-4782E12EA8BF</gtr:id><gtr:name>Swiss Federal Institute of Technology in Lausanne (EPFL)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/46814344-D2A0-4C3A-920A-598FC35388D4"><gtr:id>46814344-D2A0-4C3A-920A-598FC35388D4</gtr:id><gtr:name>University of W?rzburg</gtr:name><gtr:address><gtr:line1>Pleicherwall 2</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/FAE32A25-51D3-49EF-998F-281B3A47C212"><gtr:id>FAE32A25-51D3-49EF-998F-281B3A47C212</gtr:id><gtr:name>Helmholtz Association of German Research Centres</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/CF60CB40-8A3E-492B-B279-6D6B03F0A0B2"><gtr:id>CF60CB40-8A3E-492B-B279-6D6B03F0A0B2</gtr:id><gtr:name>University of Trieste</gtr:name><gtr:address><gtr:line1>Piazzale Europa 1</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/7314329E-003D-4ABD-A099-18C1A117FC3F"><gtr:id>7314329E-003D-4ABD-A099-18C1A117FC3F</gtr:id><gtr:name>Department of Physics</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5980849B-9E49-4B36-ADCD-CA0135F939EE"><gtr:id>5980849B-9E49-4B36-ADCD-CA0135F939EE</gtr:id><gtr:name>Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/844A3A42-4278-4EBF-BCDF-787569FA4AD3"><gtr:id>844A3A42-4278-4EBF-BCDF-787569FA4AD3</gtr:id><gtr:name>Research institute for neurodegerative diseases (DZNE)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Chemical Engineering and Biotechnology</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E4599F86-E5D9-40AD-A427-4782E12EA8BF"><gtr:id>E4599F86-E5D9-40AD-A427-4782E12EA8BF</gtr:id><gtr:name>Swiss Federal Institute of Technology in Lausanne (EPFL)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46814344-D2A0-4C3A-920A-598FC35388D4"><gtr:id>46814344-D2A0-4C3A-920A-598FC35388D4</gtr:id><gtr:name>University of W?rzburg</gtr:name><gtr:address><gtr:line1>Pleicherwall 2</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/FAE32A25-51D3-49EF-998F-281B3A47C212"><gtr:id>FAE32A25-51D3-49EF-998F-281B3A47C212</gtr:id><gtr:name>Helmholtz Association of German Research Centres</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/CF60CB40-8A3E-492B-B279-6D6B03F0A0B2"><gtr:id>CF60CB40-8A3E-492B-B279-6D6B03F0A0B2</gtr:id><gtr:name>University of Trieste</gtr:name><gtr:address><gtr:line1>Piazzale Europa 1</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/7314329E-003D-4ABD-A099-18C1A117FC3F"><gtr:id>7314329E-003D-4ABD-A099-18C1A117FC3F</gtr:id><gtr:name>Department of Physics</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5980849B-9E49-4B36-ADCD-CA0135F939EE"><gtr:id>5980849B-9E49-4B36-ADCD-CA0135F939EE</gtr:id><gtr:name>Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/844A3A42-4278-4EBF-BCDF-787569FA4AD3"><gtr:id>844A3A42-4278-4EBF-BCDF-787569FA4AD3</gtr:id><gtr:name>Research institute for neurodegerative diseases (DZNE)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/2596684E-FCB4-497B-9785-1EBAAECAA27A"><gtr:id>2596684E-FCB4-497B-9785-1EBAAECAA27A</gtr:id><gtr:firstName>Claire</gtr:firstName><gtr:surname>Michel</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/51FEE702-1899-4CF5-9EF5-E07F3F56074C"><gtr:id>51FEE702-1899-4CF5-9EF5-E07F3F56074C</gtr:id><gtr:firstName>Gabriele</gtr:firstName><gtr:surname>Kaminski Schierle</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/108E5D7C-BB74-4F03-98F3-23B31CFA48DB"><gtr:id>108E5D7C-BB74-4F03-98F3-23B31CFA48DB</gtr:id><gtr:firstName>Clemens</gtr:firstName><gtr:surname>Kaminski</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=MR%2FK02292X%2F1"><gtr:id>21B959B7-0B66-481D-B22A-CD12E998547F</gtr:id><gtr:title>MICA: Multi-parametric and super-resolution imaging of amyloidogenic proteins</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/K02292X/1</gtr:grantReference><gtr:abstractText>Alzheimer's, like other neurodegenerative diseases, is caused by aberrant forms of proteins which tend to accumulate and aggregate into shapes, which are believed to be toxic to the brain cells of affected patients. The two proteins thought to cause Alzheimer's are called amyloid-beta and tau. The precise mechanisms by which these proteins aggregate into toxic forms are unknown, but there is accumulating evidence that the shape and size of forming aggregates is intricately linked to the onset and progression of disease. Yet there are no tools to study the growth of toxic aggregates in living cells, they are simply too small to be observed with traditional techniques. For the development of potential therapies against Alzheimer's, a microscopic understanding of the events leading to aggregation, and their consequence on affected cells, is crucial. Being able to observe protein aggregation in brain cells would permit us to relate the appearance of protein &amp;quot;clumps&amp;quot; with their toxic effect. Do affected cells malfunction? In what way? What aggregate species cause the cells to malfunction? Can we identify the toxic species leading cells to 'misbehave'? Can we inhibit the formation of &amp;quot;toxic shapes&amp;quot; in living cells through the addition of potential therapeutic agents? Can we stop the spreading of toxic species from cell-to-cell? Answers to these questions require radically new approaches to look into cells, at unprecedented resolution. In our group we have recently developed a new kind of microscope, a so called optical super-resolution microscope, that is so powerful that it is capable of visualising the shape of protein aggregates directly in cultured brain cells, which we use as model systems of disease. We were the first researchers to demonstrate that it is possible to obtain 'images' of toxic protein shapes in neurones, and here we propose to use this newly developed tool to shed new light on the mechanisms that lead to the onset and propagation of disease.
The aims of our proposed research project are: 1) to identify specific species of amyloid-beta and tau in neurones and other cells present in the brain and to relate the shape, and size of these species to the appearance of disease symptoms. 2) to study amyloid-beta and tau trafficking in and out of cells and to infer on the implications of this on the possible mechanisms of disease progression. 3) to see whether potential inhibitors of protein aggregation and propagation have an effect on what we observe within the cells we study. We will test several promising anti-aggregation anti-propagation compounds that our collaborators provide.
Through the development and application of advanced microscopic imaging techniques developed in our group we aim to gain insight into the molecular level processes that lie at the heart of Alzheimer's disease and other forms of dementia. Our techniques enable us to investigate the mechanisms that lead to the misfolding and spreading of proteins and their aggregation into toxic structures in live cell model systems at very high resolution, giving insight into the mechanisms of disease and its propagation. This understanding may help in the future search for potential therapeutic agents. The knowledge and tools generated here will provide a rational basis for the development of biomarkers/diagnostics that will enable physicians to: 1) detect the disease in its earliest stages when only biochemical changes are apparent; 2) identify the stage of the disease in order to tailor therapies for individual patients; and 3) monitor response to that treatment. Knowledge of these pathways will also provide targets for therapies to repair these pathways, thereby preventing or even reversing the disease.</gtr:abstractText><gtr:technicalSummary>Amyloid proteins such as Abeta and tau are known to misfold and, eventually, to aggregate into insoluble deposits.

Questions that remain unsolved include: What are the neurotoxic amyloid species? Can the misfolded state propagate from one cell to another and has this an impact on the neuropathology? Do extracellular chaperones impact on degradation or aggregation pathways of amyloid species? The applicant's group specialises in the development and application of advanced microscopy techniques for the functional study of protein self-assembly reactions in neurodegenerative disease. We will use these tools to address the following questions:

- Abeta and tau aggregates are likely to be composed of ensembles of oligomers with different sizes and conformations and potentially differing neurotoxicity. We will use novel fluorescence-based sensors to: a) characterise the biophysical properties of these ensembles in live cells with a spatial resolution on the molecular scale; and b) correlate their biophysical properties with effects on neuropathology.

- There is increasing evidence in the literature that intracellular Abeta plays an important role in disease. In addition, the propagation of tau pathology appears to be crucial in spreading the disease to non-affected brain areas. We aim to characterise the trafficking mechanisms responsible for amyloid proteins being taken up by cells and/or released in the extracellular space.

- We will screen for different inhibitors of Abeta or tau mediated neuropathology. Firstly, we will investigate different inhibitors of amyloid proteins propagation. Secondly, we will test the potential of extracellular chaperones to interfere with amyloid protein degradation or aggregation.</gtr:technicalSummary><gtr:potentialImpactText>Over 820,000 people were affected by dementia in the UK in 2010, 24 million worldwide in 2005. This number is forecast to increase rapidly, making it one of the most pressing health issues in developed countries. The annual cost of dementia was over &amp;pound;23 billion in 2009. Our research is part of a global effort to assist the discovery of a cure for these devastating and costly diseases. Through the development and application of advanced microscopic imaging techniques developed in our group we aim to gain a mechanistic insight into the molecular level processes that lie at the heart of Alzheimer's disease and other forms of dementia. Our techniques enable us to investigate the mechanisms that lead to the misfolding of proteins and their aggregation into toxic structures in live cell model systems at molecular scale resolution, giving insight into the mechanisms of disease and its propagation. This understanding may help in the future search for potential therapeutic agents. The potential beneficiaries from this research are therefore:
- Neurobiologists studying neurodegenerative diseases (see previous section on academic beneficiaries)
- Pharmaceutical companies designing drugs will benefit from a better understanding of protein misfolding, aggregation, and dysfunction. They will also benefit from the technology we develop which could be optimised into methods for screening novel drugs and the investigation of their mode of action.
- Patients suffering from Alzheimer's disease and other forms of dementia, their carers and the community at large will benefit from a better understanding of the molecular and cellular events, which are involved in the onset and propagation of dementia. Drugs that may develop from such an understanding would greatly increase their quality and dignity of life as well as that of their relatives and carers.
- The project provides career opportunities for the named researchers through involvement and training in a cutting edge research enviroment on a topic of great socioeconomic importance. They will be trained in the development and application of state of the art molecular imaging methods, which finds use both in academic as well as in industrial research environments (e.g. in pharmaceutical companies).
- The National Physics laboratory will benefit through our collaboration in the development of optical super-resolution methods: the application of these techniques to address question of biomedical importance will provide incentives to further develop these methods (see letter of support). As the UK's national provider of measurement services, NPL will serve industry and academia on the whole with the provision of these technologies.
- The Neuroscience Consortium led by Prof. P. St. George-Hyslop, comprising research groups from across the UK and abroad will also benefit. Our technologies are critical to support the activities of these researchers, and our infrastructure and technical expertise will be made available to them free of charge.</gtr:potentialImpactText><gtr:fund><gtr:end>2016-06-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>534095</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Chemistry Bristol</gtr:department><gtr:description>Super-resolution imaging of macromolecules micelles assemblies with Ian Manners</gtr:description><gtr:id>2E23086F-CC7B-44D5-BAA4-DCC64778BF01</gtr:id><gtr:impact>None yet. But manuscript under preparation.</gtr:impact><gtr:partnerContribution>Designed, prepared and synthetised the micellar structure used for the study of micelle elongation.</gtr:partnerContribution><gtr:piContribution>Carried out super-resolution microscopy (dSTORM) imaging and feedbacks on how to prepare and design fluorescent probes for preparation of their micellar samples.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of W?rzburg</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Building of a dSTORM set up with Prof Marcus Sauer</gtr:description><gtr:id>F28ABEBF-601B-4542-9EFF-5D0B2451D5EE</gtr:id><gtr:impact>This collaboration resulted in our group having its own dSTORM set up

Kaminski-Schierle GS, Sauer M, Kaminski CF, &amp;quot;Probing Amyloid Aggregation and Morphology In Situ by Multiparameter Imaging and Super-Resolution Fluorescence Microscopy,&amp;quot; (2014) in Uversky VN, Lyubchenko YL, (eds) Bio-nanoimaging: Protein Misfolding &amp;amp; Aggregation, Academic Press, pp. 105-120

Kaminski Schierle GS, van de Linde S, Erdelyi M, Esbj&amp;ouml;rner EK, Klein T, Rees E, Bertoncini CW, Dobson CM, Sauer M, and Kaminski CF, &amp;quot;In Situ Measurements of the Formation and Morphology of Intracellular &amp;szlig;-Amyloid Fibrils by Super-Resolution Fluorescence Imaging&amp;quot;, J. Am. Chem. Soc., 133 (33), pp 12902-12905, (2011).</gtr:impact><gtr:partnerContribution>Prof Marcus Sauer contributed by exchanging on his knowledge of the dSTORM technique and the photochemistry associated with it</gtr:partnerContribution><gtr:piContribution>We contributed by building our own dSTORM set up and exchanging on the use of this technique for the study of neurodegenerative diseases</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Helmholtz Association of German Research Centres</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>German Center for Neurodegenerative Diseases (DZNE)</gtr:department><gtr:description>Imaging of amyloid proteins present in cerebrospinal fluid with Prof Mathias Jucker</gtr:description><gtr:id>CBAD381C-840B-4977-80F9-3B050CAFA325</gtr:id><gtr:impact>An original paper has been published and further collaboration will take place.
This is a collaboration between a lab which has access to rodent and human cerebrospinal fluid (our collaborators) and our lab which develops optical nanoscopy equipment.</gtr:impact><gtr:partnerContribution>The group of Prof Mathias Jucker contributed samples of cerebrospinal fluid from mice and from humans</gtr:partnerContribution><gtr:piContribution>We contributed by imaging the samples provided by the collaborators on our dSTORM optical nanoscopy microscope.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>The Identification and development of small molecule inhibitors for the aggregation of amyloid beta - David Spring</gtr:description><gtr:id>B0516FAD-2726-4444-A11C-3F2EB26CA57A</gtr:id><gtr:impact>- Output: A joint PhD student who carries out the majority of the experimental work between the three laboratories. The project is multi-diciplinary. Microscopy and cell work are carried out in our group. Microfluidic assay development is being carried out in the the Hollfelder group. Organic synthesis of the small molecule screening libraries was carried out in the Spring group
- Outcomes: None yet, but the research is still actively providing results which are expected to be submitted for publishing within the next few months.</gtr:impact><gtr:partnerContribution>- Project planning and the development of microfluidic techniques are carried out in the Hollfelder group.
- The Spring group contributed small molecule compounds for screening.</gtr:partnerContribution><gtr:piContribution>The project was developed by a joint PhD researcher within the three groups. Project planning, microscopy and cell work are carried out in our group.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Biological Sciences Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Physiology, Development and Neuroscience</gtr:department><gtr:description>Single molecule translation imaging with Christine Holt and Bill Harris</gtr:description><gtr:id>9FA1356C-0587-443A-9BD7-C5FCC3C59BBB</gtr:id><gtr:impact>None. Ongoing collaborations</gtr:impact><gtr:partnerContribution>Prepared samples of Xenopus eyes for the study of the development of neural tract in the frog. Provided the biological question.</gtr:partnerContribution><gtr:piContribution>Carried out microscopy imaging and provided tools for data analysis. Continuous feedback for improvement of the imaging and preparation conditions.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>SIM imaging of brain slices to investigate myelination with Robin Franklin</gtr:description><gtr:id>1B80FE2E-6F0E-4CB0-8813-B1E2D7F4B331</gtr:id><gtr:impact>No publications yet, but promising results presented at various small talks - eg. in college, group meetings, to the IPES CDT</gtr:impact><gtr:partnerContribution>Slicing of mouse brains, secondary anti-body staining, mounting of brain slices onto coverslip, statistical analysis of the data, biological interpretation.</gtr:partnerContribution><gtr:piContribution>Setting up the microscope, operation of the microscope, processing, reconstruction and analysis of the raw data, creation of a semi-automated image analysis protocol in Icy.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London (KCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Huntingtin propagation (Prof. G. Bates, Prof. H. Lashuel)</gtr:description><gtr:id>32DA59AD-3A9E-450F-8AE5-CBE82FD077A7</gtr:id><gtr:impact>The collaboration is multi disciplinary, involving optical microscopy and biology.
Prof. Hilal Lashuel from EPFL in Switzerland has joined this collaboration as he is an expert in the production of recombinant Huntingtin.</gtr:impact><gtr:partnerContribution>Gillian Bates was awarded the founding for the PDRA by the CHDI foundation.</gtr:partnerContribution><gtr:piContribution>We are sharing a PDRA who is funded by the CHDI foundation. We are collaborating on producing recombinant Huntingtin in order to determine the seeding capacity of the protein, which we will studied by TIRF microscopy.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute of Health and Medical Research (INSERM)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Lille (INSERM)</gtr:department><gtr:description>Super-resolution imaging of nanotubes involved in the transfer of Tau from neuron to neuron (Luc Buee)</gtr:description><gtr:id>442B858D-9181-47DD-A22E-3E2FC09FF9AC</gtr:id><gtr:impact>Invited talk given by Dr Gabriele Kaminski Schierle in Lille for a seminar on New technologies and Neurosciences</gtr:impact><gtr:partnerContribution>Will provide cells, plasmids for expression of Tau and expertise in nanotubes</gtr:partnerContribution><gtr:piContribution>We would carry out super-resolution imaging on samples</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Department of Physics</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cavendish Laboratory</gtr:department><gtr:description>dSTORM imaging of DNA origami with Ulrich Keuser</gtr:description><gtr:id>ADB9E7C9-6E42-4123-9E53-E9E63A4C95A4</gtr:id><gtr:impact>None. Ongoing collaborations. Proof of principle of imaging of their DNA origami structures under our microscope. Foster further collaboration leading to offering student projects.</gtr:impact><gtr:partnerContribution>Designed, prepared and synthetised the DNA origami structure.</gtr:partnerContribution><gtr:piContribution>Carried out super-resolution microscopy imaging using DNA origami nano-structure. Carried out analysis and simulations based on observation proving the feasibility of the imaging.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London (ICL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cambridge Imperial Centre for Single Cell Analysis (T. Knowles, F. Hollfelder, J. Edel)</gtr:description><gtr:id>03905F3C-5DE0-429C-9241-0BCE66299172</gtr:id><gtr:impact>Joint grant proposal written.</gtr:impact><gtr:partnerContribution>Joint grant proposal.</gtr:partnerContribution><gtr:piContribution>We have written a joint grant proposal to set up a brain on chip platform.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cambridge Graphene Centre</gtr:department><gtr:description>Graphene microelectrode arrays for simultaneous electrical and fluorescence measurements on neurons with Antonio Lombardo and Andrea Ferrari</gtr:description><gtr:id>B8E45427-B27F-42FC-B0B5-905CD28E4628</gtr:id><gtr:impact>Multidisciplinary activity between biotechnology and electrical engineering</gtr:impact><gtr:partnerContribution>Fabricating the graphene microelectrode arrays, and making electrical measurements on them</gtr:partnerContribution><gtr:piContribution>Growing and maintaining neuronal cell cultures, and imaging them on the graphene devices</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Research Institute for Neurodegerative Diseases (DZNE)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Study of monomeric Tau propagation from cell to cell with Prof Eckard Mandelkow</gtr:description><gtr:id>D67D052F-9F7B-4355-BB1C-089F71F6810A</gtr:id><gtr:impact>Michel CH, Kumar S, Pinotsi D, Tunnacliffe A, St George-Hyslop P, Mandelkow E, Mandelkow E-M, Kaminski CF, Kaminski Schierle GS, &amp;quot;Extracellular Monomeric Tau is Sufficient to Initiate the Spread of Tau Pathology&amp;quot;, J. Biol. Chem. (2014), 289: 956-967.

This collaboration is multi-disciplinary and involved biochemistry and physics</gtr:impact><gtr:partnerContribution>Prof Eckard Mandelkow provided us with purified recombinant Tau protein, both unlabelled and fluorescently labelled.</gtr:partnerContribution><gtr:piContribution>We have applied multi parametric and super resolution imaging techniques to the study of Tau propagation from cell to cell</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Helmholtz Association of German Research Centres</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>German Center for Neurodegenerative Diseases (DZNE)</gtr:department><gtr:description>Synthetic 3D Neuronal Networks (Prof. Heutnik, Dr. Cesare)</gtr:description><gtr:id>82D92901-5555-4112-914D-836B0BD78BE9</gtr:id><gtr:impact>Joint proposal submitted</gtr:impact><gtr:partnerContribution>Joint proposal to VW Foundation.</gtr:partnerContribution><gtr:piContribution>We have written a proposal that we submitted to the VW Foundation.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Terrahertz spectroscopy of amyloid fibrils (Prof. Axel Zeitler)</gtr:description><gtr:id>73590AA4-51BC-4AC3-8299-EF807F86A87D</gtr:id><gtr:impact>First data sets are currently analysed.</gtr:impact><gtr:partnerContribution>L-Glu based nanowires are currently investigated by THz spectroscopy in order to determine the origin of the fluorescence.</gtr:partnerContribution><gtr:piContribution>We have formed L-Glu based nanostructures which display fluorescent properties.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Lund University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>super-resolution imaging of amyloid proteins with Prof Sara Linse</gtr:description><gtr:id>5BEFBA67-93CE-4BFB-95B4-5D2DD9495580</gtr:id><gtr:impact>This partnership is still young and we hope it will develop into publication on the amyloid fibril formation kinetics. This collaboration is multi-disciplinary, the Laser Analytics group being specialised in super-resolution imaging (physics, engineering) and the group or Prof Sara Linse in protein purification and biophysical characterisation of amyloid proteins</gtr:impact><gtr:partnerContribution>The group of Prof Sara Linse provided purified amyloid protein and gave a two-week tutorial to three members of the Laser Analytics group on purification of proteins</gtr:partnerContribution><gtr:piContribution>The Laser Analytics Group is in the process of imaging amyloid protein fibril formation with super-resolution microscopy</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Swiss Federal Institute of Technology in Lausanne (EPFL)</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>Huntingtin propagation (Prof. G. Bates, Prof. H. Lashuel)</gtr:description><gtr:id>E5615761-6DAD-4F40-9B0D-0ADC401B477F</gtr:id><gtr:impact>The collaboration is multi disciplinary, involving optical microscopy and biology.
Prof. Hilal Lashuel from EPFL in Switzerland has joined this collaboration as he is an expert in the production of recombinant Huntingtin.</gtr:impact><gtr:partnerContribution>Gillian Bates was awarded the founding for the PDRA by the CHDI foundation.</gtr:partnerContribution><gtr:piContribution>We are sharing a PDRA who is funded by the CHDI foundation. We are collaborating on producing recombinant Huntingtin in order to determine the seeding capacity of the protein, which we will studied by TIRF microscopy.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Trieste</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Computational study of the instrinsic fluorescence of amyloid fibrils with Ali Hassanali and Luca Grisanti</gtr:description><gtr:id>CCB00E8D-3346-4073-89B0-069165829D38</gtr:id><gtr:impact>Paper accepted in JACS http://dx.doi.org/10.1021/jacs.5b11012 (multidisciplinary: spectroscopy, optical physics and theoretical chemistry)</gtr:impact><gtr:partnerContribution>Ab initio molecular dynamics simulations of the modeled peptide fibril systems (computational study)</gtr:partnerContribution><gtr:piContribution>Experimental study of the fluorescence properties of amyloid and peptide fibrils</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Blog post on ARUK website on dSTORM (2014)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E0C5A2EA-5619-4902-84B1-E11E2B58E4E3</gtr:id><gtr:impact>Engage with patients, carers and families about research funded by ARUK

Readers of the Alzheimer's Research UK might donate towards research.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.dementiablog.org/10000-times-smaller-pinhead/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Showcasing research to public in a hands on manner at the Cambridge Science Festival</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>2C8FDAF4-6369-430F-A44F-E9E7B6821394</gtr:id><gtr:impact>Cambridge Science Festival
Showcasing research to public in a hands on manner through various experiments organised in the dept of Chemistry including looking at neurons under a microscope.
Explaining the group's research to the public
Undertaken by several members of the group on a yearly basis since 2016

The Science Festival provides the public with opportunities to explore and discuss issues of scientific interest and concern and to raise aspirations by encouraging young people to consider a career in science, technology, engineering or mathematics.

Each year, the Festival welcomes visitors to hundreds of events and receives extensive national and local media coverage. Over 170 event coordinators organise talks, interactive demonstrations, hands-on activities, film showings and debates with the assistance of around 1,000 staff and students from departments and organisations across the University and research institutions, charities and industry in the eastern region. In addition, over 150 people volunteer their time to act as stewards to ensure visitors have a safe and enjoyable Festival experience.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.sciencefestival.cam.ac.uk/</gtr:url><gtr:year>2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ARUK Spring appeal</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BE42C66D-F4DB-4FBF-B705-C1D5D6234146</gtr:id><gtr:impact>We participated in the preparation of an appeal letter and follow up letter to potential funders of ARUK regarding the use of emergency funding by ARUK. This was also followed by a blog post

We expect some persons who received this appeal send fund to Alzheimer's Research UK for research on neurodegenerative diseases.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.dementiablog.org/every-project-counts/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Episode of Elemental Ideas on Cambridge TV	25 Minute TV show about super-resolution microscopy</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A01828FB-36C5-43B3-BFDB-2AA40DF8CEAC</gtr:id><gtr:impact>Clemens Kaminski, Gabriele Kaminski Schierle, Colin Hockings, Florian Str&amp;ouml;hl, Nathan Curry

Episode of Elemental Ideas on Cambridge TV 25 Minute TV show about super-resolution microscopy 
01/07/2016 Explaining research to the public through a video of our group's lab and research work, with interviews of the two group leaders and several postdoctoral research associates and PhD students.
The videos can be accessed for free online.

Elemental Ideas is Cambridge TV's science magazine programme. They've produced more than 50 programmes since August 2015, covering research topics including string theory, diabetes, exoplanets, vulcanology, epigenetics and the wildlife of New Zealand.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.cambridge-tv.co.uk/super-resolution-microscopy/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk and lab tour to funders of ARUK, May 2015</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>D0C3BF18-6072-4020-BCA7-5FFBA6B505EF</gtr:id><gtr:impact>Engage with funders on the research carried out thanks to their donations</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Research exchange meeting with DAAD students</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5BBE1132-A3FF-472A-8E97-029D94D3E5F0</gtr:id><gtr:impact>Organised a visit (lab tours and research lectures) for German Biophysics students funded under the &amp;quot;Studienstiftung&amp;quot; programme</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk on A short history of Microscopy, Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>FB59C817-91F4-4A79-9595-DF8337574F2F</gtr:id><gtr:impact>Public lecture on A short history of Microscopy</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview on BBC Radio Cambridge 2014</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>E6876941-EA4B-4022-8711-79406E7145DB</gtr:id><gtr:impact>This activity was a 3 minutes interview on super-resolution interview used in research on neurodegenerative diseases

Engage with the wide public about advances in research on Alzheimer's disease</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk and lab tour to funders of ARUK, Feb 2016</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>85FB87E5-BCFA-455B-B2BD-95FDF07D0E46</gtr:id><gtr:impact>Engage with funders on the research carried out thanks to their donations</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Superresolution public video</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FEC9EAF4-F282-4E20-A4FC-61C866CA9C9E</gtr:id><gtr:impact>Video interview and research video to explain superresolution microscopy in medical research to a lay audience. Currently &amp;gt;14000 views.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.youtube.com/watch?v=W-0GWbOFT3w</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk, tour of the lab and Q&amp;A for 15 employees of ARUK</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>544A9115-43BA-4195-AF47-E8B98BE891DC</gtr:id><gtr:impact>This activity gave a clearer understanding to employees of ARUK and to readers of the ARUK blog of the work carried out by researchers studying dementia

One employee of ARUK wrote a blog post on his visit, which increased the number of people reached through this activity.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.dementiablog.org/tau-proteins/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview by ARUK at the Copenhagen AAIC conference</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7165643D-42B5-40DD-BAB0-921B42471110</gtr:id><gtr:impact>This activity resulted into engaging with readers of the Alzheimer's Research UK blog about research presented by Dr Claire Michel on a poster at the Alzheimer's Association International Conference 2014

With this interview funders of Alzheimer's Research UK received information regarding how their donations are used by researchers and what results researchers obtain.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pint of Science Festival Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B73758B8-8739-45D9-8AB2-203A5E5AD949</gtr:id><gtr:impact>Public lecture at Pint of Science Festival.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Alzheimer Research UK Cambridge Network travel grant</gtr:description><gtr:end>2013-10-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>BFB07F70-B6FA-42B2-AC95-57B9999F6164</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Council Newton-Katip Celebi fund travel grant (Miranda Robbins)</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>British Council</gtr:fundingOrg><gtr:id>D504A82A-A2BF-4ED6-80D5-CA62BA932AC2</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>760940</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>&amp;quot;THE ROLE OF THE ALZHEIMER'S DISEASE RISK GENE PICALM IN BLOOD BRAIN BARRIER TRANSPORT, ALZHEIMER'S DISEASE AND AMYLOID ANGIOPATHY &amp;quot;</gtr:description><gtr:end>2019-05-02</gtr:end><gtr:fundingOrg>MRC-UK</gtr:fundingOrg><gtr:fundingRef>MR/N012453/1</gtr:fundingRef><gtr:id>8780063A-22CC-4186-BDCF-63EBE5115EF1</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>400000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Liquid droplets and hydrogels in health and disease</gtr:description><gtr:end>2021-12-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>B042A357-2E03-4293-B368-E60BF45A759D</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>273287</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>SUPUVIR Marie Curie Consortium</gtr:description><gtr:end>2021-12-02</gtr:end><gtr:fundingOrg>European Commission (EC)</gtr:fundingOrg><gtr:fundingRef>722380</gtr:fundingRef><gtr:id>88AF0F59-1061-4F96-872F-52BECA108968</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5000000</gtr:amountPounds><gtr:country>China, People's Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Cambridge Infinitus Research Centre</gtr:description><gtr:end>2020-08-02</gtr:end><gtr:fundingOrg>Infinitus</gtr:fundingOrg><gtr:id>06CB2DE1-9B42-4E0E-A0B2-2C66F0E681D3</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2015-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>72000</gtr:amountPounds><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:currCode>CHF</gtr:currCode><gtr:currCountryCode>Switzerland</gtr:currCountryCode><gtr:currLang>it_CH</gtr:currLang><gtr:description>Swiss National Science Foundation</gtr:description><gtr:end>2016-04-02</gtr:end><gtr:fundingOrg>Swiss National Science Foundation</gtr:fundingOrg><gtr:id>1ABD8CF0-A486-42A3-86E5-23EABE38E6C2</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>205269</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Liquid droplets and hydrogels:protein phasetransition in health and disease</gtr:description><gtr:end>2021-01-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:fundingRef>203249/Z/16/Z</gtr:fundingRef><gtr:id>6C673587-78F2-4975-BF5D-1EA5DF09B47A</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>9490</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UK-KOREA COLLABORATION FOR NEURODEGENERATIVE DISEASE</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>MRC-UK</gtr:fundingOrg><gtr:id>F2283169-6046-4600-BAFA-970A91FAC4AE</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2016-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>140400</gtr:amountPounds><gtr:country>Germany, Federal Republic of</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Research Fellowship Deutsche Forschungsgemeinschaft (DFG)</gtr:description><gtr:end>2018-03-02</gtr:end><gtr:fundingOrg>German Research Foundation (DFG)</gtr:fundingOrg><gtr:fundingRef>LA 3609/2-1</gtr:fundingRef><gtr:id>DDAA20C8-E310-4F21-A879-B2BA3DB89576</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9F93B364-0801-47D2-A952-6FF7AA17210F"><gtr:id>9F93B364-0801-47D2-A952-6FF7AA17210F</gtr:id><gtr:title>Direct observation of heterogeneous amyloid fibril growth kinetics via two-color super-resolution microscopy.</gtr:title><gtr:parentPublicationTitle>Nano letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f63daf262de36628f14c6dd55e0b6d52"><gtr:id>f63daf262de36628f14c6dd55e0b6d52</gtr:id><gtr:otherNames>Pinotsi D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1530-6984</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2742F27A-C9C1-4C21-A708-7815E4EE23F2"><gtr:id>2742F27A-C9C1-4C21-A708-7815E4EE23F2</gtr:id><gtr:title>Optical Super-Resolution Imaging of ?-Amyloid Aggregation In Vitro and In Vivo: Method and Techniques.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f63daf262de36628f14c6dd55e0b6d52"><gtr:id>f63daf262de36628f14c6dd55e0b6d52</gtr:id><gtr:otherNames>Pinotsi D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9AD8B83A-D8DC-4FCE-BDF1-7958151233FB"><gtr:id>9AD8B83A-D8DC-4FCE-BDF1-7958151233FB</gtr:id><gtr:title>Advanced imaging of tau pathology in Alzheimer Disease: New perspectives from super resolution microscopy and label-free nanoscopy.</gtr:title><gtr:parentPublicationTitle>Microscopy research and technique</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8f495043cd9165a79cfa163a24f8044c"><gtr:id>8f495043cd9165a79cfa163a24f8044c</gtr:id><gtr:otherNames>Schierle GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1059-910X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/941B6656-FA1B-4A2E-97C2-111AE0885176"><gtr:id>941B6656-FA1B-4A2E-97C2-111AE0885176</gtr:id><gtr:title>Two distinct ?-sheet structures in Italian-mutant amyloid-beta fibrils: a potential link to different clinical phenotypes.</gtr:title><gtr:parentPublicationTitle>Cellular and molecular life sciences : CMLS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b6d7d4c382c476e2250eea6df12bc7e5"><gtr:id>b6d7d4c382c476e2250eea6df12bc7e5</gtr:id><gtr:otherNames>Hubin E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1420-682X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/49F97B97-6C04-4824-9325-318EA5175F60"><gtr:id>49F97B97-6C04-4824-9325-318EA5175F60</gtr:id><gtr:title>ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5a4031368e0dfff5a4f0edaea20b575f"><gtr:id>5a4031368e0dfff5a4f0edaea20b575f</gtr:id><gtr:otherNames>Murakami T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3449CCB1-DACD-4CF2-A57A-26099B6085D4"><gtr:id>3449CCB1-DACD-4CF2-A57A-26099B6085D4</gtr:id><gtr:title>Nanoscopic insights into seeding mechanisms and toxicity of a-synuclein species in neurons.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f63daf262de36628f14c6dd55e0b6d52"><gtr:id>f63daf262de36628f14c6dd55e0b6d52</gtr:id><gtr:otherNames>Pinotsi D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/581BF48B-C198-4A7F-8E2C-3EBFECAC850B"><gtr:id>581BF48B-C198-4A7F-8E2C-3EBFECAC850B</gtr:id><gtr:title>A Guide to Structured Illumination TIRF Microscopy at High Speed with Multiple Colors.</gtr:title><gtr:parentPublicationTitle>Journal of visualized experiments : JoVE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6361dd17297275666f22f3b0c8b7e1fc"><gtr:id>6361dd17297275666f22f3b0c8b7e1fc</gtr:id><gtr:otherNames>Young LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1940-087X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6323D0BB-C559-4DCA-9FE2-39BA92CB4294"><gtr:id>6323D0BB-C559-4DCA-9FE2-39BA92CB4294</gtr:id><gtr:title>Frontiers in structured illumination microscopy</gtr:title><gtr:parentPublicationTitle>Optica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1eda85e22263137dad85b489ead6ead9"><gtr:id>1eda85e22263137dad85b489ead6ead9</gtr:id><gtr:otherNames>Str?hl F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/389F6349-36EF-496B-B714-F3148A3D91FB"><gtr:id>389F6349-36EF-496B-B714-F3148A3D91FB</gtr:id><gtr:title>Analyzing receptor assemblies in the cell membrane using fluorescence anisotropy imaging with TIRF microscopy.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6c84dd61bbb7400f0bd8a9e03465821e"><gtr:id>6c84dd61bbb7400f0bd8a9e03465821e</gtr:id><gtr:otherNames>Erdelyi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EAED0CE4-B0DE-4D10-8082-1CA6884083C8"><gtr:id>EAED0CE4-B0DE-4D10-8082-1CA6884083C8</gtr:id><gtr:title>Probing amyloid protein aggregation with optical superresolution methods: from the test tube to models of disease.</gtr:title><gtr:parentPublicationTitle>Neurophotonics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/21586382c9f3c52906ba1f46fb3b0987"><gtr:id>21586382c9f3c52906ba1f46fb3b0987</gtr:id><gtr:otherNames>Kaminski CF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2329-423X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1F91DDF1-7472-4AE1-ACBB-68E359284160"><gtr:id>1F91DDF1-7472-4AE1-ACBB-68E359284160</gtr:id><gtr:title>Structural analysis of herpes simplex virus by optical super-resolution imaging.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/42e61f9255d87d755a5b1cd5f9d88559"><gtr:id>42e61f9255d87d755a5b1cd5f9d88559</gtr:id><gtr:otherNames>Laine RF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7C9F4653-D02D-4054-8BA4-E66EA635E174"><gtr:id>7C9F4653-D02D-4054-8BA4-E66EA635E174</gtr:id><gtr:title>Super-resolution fluorescent methods: where next for super-resolution?</gtr:title><gtr:parentPublicationTitle>Methods and Applications in Fluorescence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e76fdead3963d6ef738e96edd3fbb0b8"><gtr:id>e76fdead3963d6ef738e96edd3fbb0b8</gtr:id><gtr:otherNames>Knight A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B6D3E2DA-28C2-44FE-A861-3E21DE3BB65C"><gtr:id>B6D3E2DA-28C2-44FE-A861-3E21DE3BB65C</gtr:id><gtr:title>Structural basis of synaptic vesicle assembly promoted by a-synuclein.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/92c9c1996ce999a43d645cebc5808eb9"><gtr:id>92c9c1996ce999a43d645cebc5808eb9</gtr:id><gtr:otherNames>Fusco G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/984641FC-8EAB-45A0-894F-10A7E8276EDC"><gtr:id>984641FC-8EAB-45A0-894F-10A7E8276EDC</gtr:id><gtr:title>From single-molecule spectroscopy to super-resolution imaging of the neuron: a review</gtr:title><gtr:parentPublicationTitle>Methods and Applications in Fluorescence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/542948cbb65cd59b86e7e79ac84f8cf7"><gtr:id>542948cbb65cd59b86e7e79ac84f8cf7</gtr:id><gtr:otherNames>Laine R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3AD39FAC-2139-4F81-A3EF-D358FC7B71CA"><gtr:id>3AD39FAC-2139-4F81-A3EF-D358FC7B71CA</gtr:id><gtr:title>Highly potent soluble amyloid-? seeds in human Alzheimer brain but not cerebrospinal fluid.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2cf472c06c0c23f554d3ad3fe70bd3b2"><gtr:id>2cf472c06c0c23f554d3ad3fe70bd3b2</gtr:id><gtr:otherNames>Fritschi SK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C4639036-7CED-4D2E-92CE-7B946EB1C7F0"><gtr:id>C4639036-7CED-4D2E-92CE-7B946EB1C7F0</gtr:id><gtr:title>Extracellular monomeric tau protein is sufficient to initiate the spread of tau protein pathology.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c30f45e650459a89d0794cfa90ef60d9"><gtr:id>c30f45e650459a89d0794cfa90ef60d9</gtr:id><gtr:otherNames>Michel CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E39F791B-4E12-4C48-A781-22294323E410"><gtr:id>E39F791B-4E12-4C48-A781-22294323E410</gtr:id><gtr:title>Proton Transfer and Structure-Specific Fluorescence in Hydrogen Bond-Rich Protein Structures.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f63daf262de36628f14c6dd55e0b6d52"><gtr:id>f63daf262de36628f14c6dd55e0b6d52</gtr:id><gtr:otherNames>Pinotsi D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EEBAF7C3-E553-4F64-A75B-044192D3AA19"><gtr:id>EEBAF7C3-E553-4F64-A75B-044192D3AA19</gtr:id><gtr:title>Proton Transfer and Structure-Specific Fluorescence in Hydrogen Bond-Rich Protein Structures.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f63daf262de36628f14c6dd55e0b6d52"><gtr:id>f63daf262de36628f14c6dd55e0b6d52</gtr:id><gtr:otherNames>Pinotsi D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/K02292X/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>